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MidodrineAbstract Background: Hyperdynamic circulatory state in liver cirrhosis is characterized by
increased splanchnic blood ﬂow and renal vasoconstriction.
Aim: To evaluate the relationship between renal resistive indices (RI) and HCV liver cirrhosis
severity and RI value in predicting 6 month survival of those patients. Also we aimed to assess
the effect of midodrine on RI.
Patients and methods: 120 patients with HCV liver cirrhosis and 40 healthy controls were enrolled
in the study. INR, total bilirubin, albumin, creatinine and sodium were measured in all patients.
Both patients and controls underwent abdominal ultrasound with duplex Doppler examination
of the kidneys with RI calculated. Patients were followed for 6 months. Surviving patients with
highest risk underwent renal duplex with RI calculation (RI2). They then received oral midodrine
at a dose of 7.5 mg three times daily for 3 months with revaluation of RI (RI3).
1080 S.A. Abdel-bary et al.Results: 57 (47.5%) patients had high RI (RI > 0.7) while 63 (52.5%) patients had normal RI.
Patients had signiﬁcantly higher RI than healthy controls (P< 0.001). There was a signiﬁcant posi-
tive correlation between RI and MELD, MELD-Na, and Child class (r= 0.859, r= 0.769,
rho = 0.56 respectively and P< 0.001). Patients with RI > 0.73 are at higher risk of death within
6 months (P< 0.001). Administration of midodrine resulted in no signiﬁcant difference in RI in the
37 surviving patients with baseline RI > 0.73 (P= 0.1605).
Conclusion: RI is strongly correlated with liver cirrhosis severity and had comparable prognostic
value with MELD score. Midodrine had no signiﬁcant effect on RI in high risk patients.
 2014 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.1. Introduction
Despite notable splanchnic arterial vasodilatation and hyper-
dynamic circulation, patients with cirrhosis show increased
renal arterial tone, resulting in poor renal perfusion (1).
Decreased peripheral vascular resistance with activation of
compensatory mechanisms [the sympathetic nervous system
(SNS), renin-angiotensin-aldosterone system (RAAS) and
antidiuretic hormone (ADH)] leads to renal vasoconstriction
(2).
The intra-renal resistive index (RI) is the most frequently
used parameter to assess intra-renal resistance and is calcu-
lated based on intra-renal duplex Doppler ultrasound mea-
surements (3). Renal arterial RI was reported to be higher in
cirrhotic patients than in healthy controls and also it is higher
in cirrhotic patients with ascites than in cirrhotic patients with-
out ascites (4).
In predicting the outcomes of patients with cirrhosis, the
Model for End-Stage Liver Disease (MELD) has been shown
to be superior to the traditional Child–Pugh classiﬁcation
and other systems of risk stratiﬁcation (5,6). Several studies
have shown that hyponatremia is a strong predictor of early
mortality, independent of MELD score (7). A modiﬁed score
including serum sodium, termed MELD-Na, has been pro-
posed as an alternative to MELD score. The accuracy of
MELD-Na was shown to be slightly superior to that of MELD
in candidates for transplantation (8).
However, in liver cirrhosis, serum creatinine (one compo-
nent of MELD score) is inaccurate in the diagnosis of renal
dysfunction as it overestimates renal function due to decreased
creatinine production by the liver, protein calorie malnutrition,
and muscle wasting (9). Thus, it is still necessary to develop
improved prognostic markers feasible in daily practice.
Recently, Go¨tzberger et al. (10) demonstrated that the RI is
not inferior in sensitivity and speciﬁcity to the MELD score.
Their study conﬁrms that the RI is an effective, noninvasive
and economical functional test that provides useful informa-
tion for the prognosis and management of cirrhotic patients.
According to their study, elevated RIs may even disclose pro-
gress of the liver disease before changes in laboratory results
and cirrhotic patients with elevated RIs have impaired short-
and long-term survival. Thus RI may help identify high-risk
patients that require special therapeutic care.
Midodrine is a potent and selective, peripherally acting oral
alpha adrenergic receptor agonist with little effect on the beta-
adrenergic receptors in the heart (11). Midodrine has been used
to improve renal hemodynamics in cirrhotics with ascites. In
these patients, it increases effective arterial blood volume bycausing splanchnic vasoconstriction and improves renal perfu-
sion and glomerular ﬁltration (12).
1.1. Aim of the study
The aim of the current study was to evaluate the relationship
between renal resistive indices and HCV liver cirrhosis severity
assessed by Child-Pugh classiﬁcation, MELD and MELD-Na,
and also we aimed at assessing the value of renal resistive indi-
ces in predicting 6 month survival of those patients. This study
also aimed at assessing the short term effect of midodrine on
renal resistive indices in high risk patients.
2. Patients and methods
2.1. Patients
A total of 120 patients with HCV liver cirrhosis (proved by
laboratory and radiological studies) attending the Hepatology
outpatient clinics or admitted at the Internal Medicine depart-
ment, Ain Shams University Hospital were enrolled. 40
healthy controls were also enrolled in the study. Patients with
any other condition leading to renal affection including hyper-
tension, diabetes mellitus, reno-vascular kidney disease, spon-
taneous bacterial peritonitis, diagnosis of hepatorenal
syndrome at time of inclusion into the study, gastrointestinal
bleeding and chronic kidney disease of any etiology were
excluded as all the previously mentioned conditions affect
renal resistive indices. The study was performed according to
the ethical standards for human experimentation and was
approved by the scientiﬁc committee of Ain Shams University.
An informed consent was obtained from the selected patients
after explaining the aim of the study and the nature of the
investigations required. Diagnosis of HCV related liver cirrho-
sis was based on clinical, laboratory and radiological data.
All patients and controls were subjected to thorough med-
ical history and clinical examination. Patients underwent lab
investigation (INR, total bilirubin, albumin, serum creatinine,
sodium).
2.2. Methods
Both patients and controls underwent abdominal ultrasound
with duplex Doppler examination of the kidneys. All subjects
were examined after eight hours fasting. They underwent
abdominal ultrasonography (US) using US equipment with
color Doppler capability using convex linear (2.8 – 5 MHz)
Table 2 Baseline characteristics of the studied patients.
Parameter Patients Controls
(n= 120) (n= 60)
Value of renal resistive index in hepatitis C virus related liver cirrhosis 1081transducer (General electric LOGIQ P6 device). The RI was
automatically calculated by the US equipment. Intra-renal
resistance was measured on inter-lobar arteries three times in
different regions of each kidney (upper, middle, and lower
poles) and the mean value was calculated. Subsequently, a
mean RI was calculated for each subject (mean of both kid-
neys). RI > 0.7 was considered high (13).
The MELD and MELD-Na scores were calculated in all
patients according to the following formulae: MELD= 9.57
loge [Creatinine (mg/dL)] + 3.78 loge [Bilirubin (mg/dL)] +
11.2 loge [International Normalized Ratio] + 6.43 (14).
MELD-Na =MELD – Na – [0.025 ·MELD · (140 – Na)]
+ 140 (15). Also Child-Pugh classiﬁcation was calculated for
all studied patients to assess the severity of liver disease,
depending on patients’ clinical and laboratory data (ascites,
hepatic encephalopathy, serum albumin, serum bilirubin, and
international normalized ratio INR) (16) (Table 1).
Patients were prospectively monitored for 6 months. The
end points were death (reported by patient’s relatives in all
cases) or survival at the day of the follow-up visit after
6 months of the initial assessment. RI value with highest
accuracy (best sensitivity and speciﬁcity) for 6 month survival
prediction was determined from ROC curve and surviving
patients with RI higher than this value underwent renal duplex
with RI calculation (RI2).
Surviving patients received oral midodrine at a dose of
7.5 mg three times daily for 3 months with follow up renal
duplex at the end of the 3 months with RI calculation (RI3).
2.3. Statistical analysis
Data were analyzed using SPSS version 17 (SPSS Inc., Chicago,
IL, USA). Data were described as mean ± standard deviation
for quantitative variables and as number and percentage for
qualitative variables. The following tests were used: Student’s
t-test, paired t test, ANOVA, Pearson correlation coefﬁcient,
Spearman correlation coefﬁcient and receiver operating charac-
teristic curve (ROC) with calculation of area under receiver
operating characteristic curve (AUROC) and cutoff value with
best accuracy. Survival curves were evaluated and compared
using the Kaplan Meier method and the log-rank test. P value
<0.05 was used to express statistically signiﬁcant difference.
3. Results
The current study included 120 patients with HCV related liver
cirrhosis with their mean age 50.55 ± 8.096 years and 40Table 1 Modiﬁed Child-Pugh classiﬁcation of the severity of
liver disease.
Parameter Points assigned
1 2 3
Albumin >3.5 g/dL 2.8–3.5 g/dL <2.8 g/dL
Bilirubin <2 mg/dL 2–3 mg/dL >3 mg/dL
INR <1.7 1.7–2.3 >2.3
Ascites None Grade 1–2 Grade 3–4
Encephalopathy Absent Slight Moderate
N.B. A total Child-Turcotte-Pugh score of 5–6 is considered class
A; 7–9 is class B; and 10–15 is class C.healthy controls with their mean age 50.1 ± 6.46 years. The
patients included 46 (38.3%) female patients and 74 (61.7%)
male patients while the control group included 16 (40%)
female patients and 24 (60%) male patients. 6 (5%) patients
were Child A, 42 (35%) patients were Child B and 72 (60%)
patients Child C. Patients’ mean MELD score was
17.92 ± 4.75 while their mean MELD Na score was
21.9 ± 5.94. Ascites was present in 84 (70%) patients. 57
(47.5%) patients had high renal resistive index (RI > 0.7)
while 63 (52.5%) patients had normal RI (RI 6 0.7) (Table 2).
Patients with liver cirrhosis had signiﬁcantly higher RI than
healthy controls (0.69 ± 0.09 vs. 0.49 ± 0.07, P< 0.001). Cir-
rhotic patients with ascites (n= 84) had signiﬁcantly higher RI
than cirrhotic patients without ascites (n= 36) (0.71 ± 0.08
vs. 0.65 ± 0.08, P< 0.001). ANOVA comparison between
cirrhotic patients with ascites, cirrhotic patients without ascites
and normal controls showed a signiﬁcant difference between
the three groups (P< 0.001) with patients with cirrhosis and
ascites having highest mean RI and controls having the lowest
mean RI (Table 3).
RI had a signiﬁcant positive correlation with Child class
with rho = 0.56 and P< 0.001 (Fig. 1). ANOVA comparison
between different Child classes as regards RI showed a
signiﬁcant difference (P< 0.001) with Child C patients having
highest mean RI followed by Child B patients and lastly Child
A patients (0.73 ± 0.07, 0.64 ± 0.08 and 0.58 ± 0.02,
respectively).
There was a signiﬁcant positive correlation between RI and
MELD (r= 0.859, P< 0.001) (Fig. 2) and MELD Na
(r= 0.769, P< 0.001) (Fig. 3).
RI also had a signiﬁcant positive correlation with creatinine
(r= 0.381, P< 0.001), INR (r= 0.591, P< 0.001) and total
bilirubin (r= 0.593, P< 0.001). There was a signiﬁcant
negative correlation between RI and albumin (r= 0.407,
P< 0.001) and Na (r= 0.341,P< 0.001) (Table 4).
Patient with high RI (n= 57) had signiﬁcantly higher
MELD score (21.63 ± 3.15 vs. 14.56 ± 3.2, P< 0.001),
MELD-Na (25.88 ± 3.55 vs. 18.3 ± 5.35, P< 0.001) and
serum creatinine (1.15 ± 0.58 vs. 0.83 ± 0.25,P< 0.001) than
patients with normal RI (n= 63) (Table 5).
10 (8.3%) patients out of 120 died within 6 months.
Resistive index ROC curve analysis for 6 month predictionAge (years) 50.55 ± 8.1 50.1 ± 6.46
Male (%)/Female (%) 74 (61.7)/46 (38.3) 24(60)/16(40)
Ascites n (%) 84 (70)
Encephalopathy n (%) 34 (28.3)
Serum albumin (mg/dL) 2.36 ± 0.49
Total bilirubin (mg/dL) 5.1 ± 3.51
INR 1.61 ± 0.36
Serum sodium (mEq/L) 132.03 ± 6.31
Serum creatinine (mg/dL) 0.98 ± 0.47
MELD score 17.92 ± 4.75
MELD-Na score 21.9 ± 5.94
Child-Pugh A (%)/B (%)/C (%) 6 (5)/42 (35)/72 (60)
Intrarenal resistive index 0.69 ± 0.09 0.49 ± 0.07
High RI (%)/Normal RI (%) 57 (47.5)/63 (52.5)
Table 3 Comparison between cirrhotic patients with ascites, cirrhotic patients without ascites and controls as regards RI.
Cirrhotic ascitic Cirrhotic non-ascitic Controls
(n= 84) (n= 36) (n= 40)
RI (mean ± SD) 0.71 ± 0.08 0.65 ± 0.08 0.49 ± 0.07 P< 0.001
Fig. 1 Normal renal duplex examination (control).
1082 S.A. Abdel-bary et al.of survival showed that RI had AUROC= 0.903 (95% CI:
0.835–0.949 and P< 0.001). At a cutoff value of RI > 0.73,
renal resistive index had sensitivity of 100% and speciﬁcity
of 66.36%. MELD score ROC curve for 6 month prediction
of survival showed that MELD had AUROC= 0.995 (95%
CI: 0.959–0.998 and P< 0.001). At a cutoff value of
MELD> 23, MELD score showed sensitivity of 100% and
speciﬁcity of 96.36% (Table 6). Comparing RI and MELD
score ROC curves showed no signiﬁcant difference (P= 0.139)
(Fig. 4).
Kaplan Meier survival analysis with log-rank test showed
that patients with RI > 0.73 (n= 47) are at higher risk of
mortality within 6 months compared with patients with
RI 6 0.73 (n= 73) (P< 0.001) (Fig. 5). Also, patients with
MELD> 23 (n= 14) had higher risk of mortality within
6 months than those with MELD 6 23 (n= 106) with
P< 0.001 (Fig. 6).
At the end of the 6 month follow-up period, 37 surviving
patients had baseline RI (RI1) >0.73. Those patients received
oral midodrine at a dose of 7.5 mg TID for the next 3 months.
Four (10.8%) patients died while receiving midodrine. In the
surviving patients (n= 33), paired t test showed no signiﬁcant
difference between RIs before midodrine administration (RI2)
and after midodrine administration (RI3) (0.7794 ± 0.0228 vs.
0.7806 ± 0.0226, P= 0.1605 Fig. 7).
4. Discussion
Renal vasoconstriction has been documented in several series
of cirrhotic patients on the base of increased intra-renal RI(17). It had been demonstrated that cirrhotic patients with
abnormal RI and normal renal function at baseline are at
greater risk for subsequent development of hepatorenal
syndrome (18–21). RI, also correlated with the severity of liver
cirrhosis and duplex Doppler US of renal artery, was
suggested as a part of the routine follow up of cirrhotic
patients (22).
In the current study, patients with liver cirrhosis had a sig-
niﬁcantly higher renal resistive index (RI) than healthy con-
trols (P< 0.001). This agrees with the study by Cazzaniga
et al. (23) who showed that intra-renal RI was signiﬁcantly
higher in patients with cirrhosis than in healthy subjects. This
also agrees with the studies by Ustundag et al. (24), Fouad
et al. (25) and Koda et al. (26) reporting higher RI in cirrhotic
patients than healthy controls (P< 0.05, P< 0.01 and
P< 0.01, respectively).
Resistive index may be inﬂuenced by the presence of ascites,
where its mean value was higher among patients with ascites
(P< 0.001). Besides, ANOVA comparison between cirrhotic
patients with ascites, cirrhotic patients without ascites and nor-
mal controls showed a signiﬁcant difference between the three
groups (P< 0.001) with patients with cirrhosis and ascites
having highest mean RI and controls having the lowest mean
RI.
Similar results were seen in previous studies that noticed a
higher RI among cirrhotic ascitic patients than normal subjects
(P< 0.01) (27,28). Similarly, three studies had shown RI being
signiﬁcantly higher in group of patients with cirrhosis and asci-
tes than cirrhotic non-ascitic and in cirrhotic non-ascitic
patients than in healthy controls: Rendo´n Unceta et al. (29)
Fig. 2 Initial renal duplex for a patient with increased RI.
Fig. 3 Renal duplex for the same patient after 6 months.
Table 4 Correlation between RI and laboratory data.
Laboratory data Resistive index (RI)
r P
Serum creatinine 0.381 <0.001
Total bilirubin 0.593 <0.001
Serum albumin 0.407 <0.001
Serum sodium 0.341 <0.001
INR 0.591 <0.001
Table 5 Comparison between patients with high and normal
RI as regards MELD, MELD-NA and serum creatinine.
High RI (>0.7) Normal RI (60.7) P
(n= 57) (n= 63)
MELD 21.63 ± 3.15 14.56 ± 3.2 <0.001
MELD-Na 25.88 ± 3.55 18.3 ± 5.35 <0.001
Serum creatinine 1.15 ± 0.58 0.83 ± 0.25 <0.001
Value of renal resistive index in hepatitis C virus related liver cirrhosis 1083(P< 0.01 and P< 0.05, respectively), Celebi et al. (30)
(P< 0.01 and P< 0.01, respectively) and Sacerdoti et al. (31)
(P< 0.05 and P< 0.01, respectively).Of our study cirrhotic population, 57 (47.5%) patients had
high RI deﬁned as RI > 0.7 while 63 (52.5%) patients had
normal RI deﬁned as RI 6 0.7. This is to be compared with
the percentage of patients having high RI in the studies by
Table 6 Comparison between RI and MELD score as regards
ROC curves.
Parameter RI MELD
AUROC 0.903 0.995
95% CI 0.835–0.949 0.959–0.998
P value <0.001 <0.001
Cutoﬀ value 0.73 23
Sensitivity (%) 100 100
Speciﬁcity (%) 66.36 96.36
1.0 1.5 2.0 2.5 3.0
0.85
0.80
0.75
0.70
0.65
0.60
0.55
0.50
Child
R
I
Fig. 5 Correlation between Child-Pugh classiﬁcation and renal
resistive index.
1084 S.A. Abdel-bary et al.Umbro et al. (65%) (32), Pompili et al. (50%) (33) and Colli
et al. (36%) (28).
A positive correlation between RI and MELD (r= 0.86,
P< 0.001) and MELD-Na (r= 0.769, P< 0.001) was noted
in our study. Patients with high RI (n= 57) had signiﬁcantly
higher MELD score (P< 0.001), MELD-Na (P< 0.001)
and serum creatinine (P< 0.001) than patients with normal
RI (n= 63). These results are in agreement with the study
by Umbro et al. (32).
Another ﬁnding noted in our study and other studies
(26,36) is the positive correlation between RI and Child-Pugh
classiﬁcation (rho = 0.56, P< 0.001). Moreover, Child C
patients had the highest RI followed by Child B patients and
lastly Child A patients (P< 0.001). These ﬁndings are in con-
cordance with many studies revealing that patients with Child
C had higher RI than Child B and those in Child B had higher
RI than those in Child A: Yan et al. (P< 0.01) (34); Al-Kare-
emy et al. (P< 0.01) (35) and Sacerdoti et al. (31).
Our study also showed a signiﬁcant positive correlation
between RI and serum creatinine (r= 0.381, P< 0.001). This
is in contrast to Pompili et al. (33) who reported no signiﬁcant
correlation between RI and serum creatinine.
In our study, 10 (8.3%) patients out of 120 died within
6 months. We found no signiﬁcant difference (P= 0.139)
between RI and MELD ROC curves for 6 month predictionFig. 4 Renal duplex for the same patiof survival (AUROC= 0.903 and 0.995 respectively). Simi-
larly, Go¨tzberger et al. (10) showed no signiﬁcant difference
between RI and MELD score in predicting survival
(AUROC= 0.722 and 0.724, respectively) (Figs. 8–10).
Kaplan Meier survival analysis with log-rank test showed
that patients with RI > 0.73 and patients with MELD> 23
are at higher risk of mortality within 6 months than other
patients (P< 0.001). This is to be compared with results of
Go¨tzberger et al.’s (10) study which revealed a signiﬁcant dif-
ference in survival between patients with RI > 0.74 and
RI 6 0.74 in the short-term as well as the long-term course
(P= 0.037).
Patients with baseline RI > 0.73 surviving the 6 month fol-
low-up period received oral midodrine at a dose of 7.5 mg TID
for the next 3 months. We found no improvement in RI
(P= 0.1605) on comparing RI before and after midodrine
administration. In the study by Angeli et al. (12), acuteent after midodrine administration.
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Fig. 6 Correlation between MELD and renal resistive index.
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MELD
RI
0 20 40 60 80 100
100
80
60
40
20
0
100-Specificity
S
en
si
tiv
ity
Fig. 8 Comparison between MELD and RI ROC curves in predicting survival (P= 0.139).
 
Fig. 9 Kaplan Meier survival analysis curve for RI. (Continuous
line: RI 6 0.73, dotted line: RI > 0.73).
Fig. 10 Kaplan Meier survival curve for MELD score. (Con-
tinuous line: MELD 6 23, dotted line: MELD 23).
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Fig. 11 RI values before midodrine administration (RI2) and
after midodrine administration (RI3).
1086 S.A. Abdel-bary et al.administration of midodrine was associated with improvement
of renal hemodynamic, renal perfusion and glomerular ﬁltra-
tion (Fig. 11).
5. Conclusions
Our observations suggest that RI is strongly correlated with
liver cirrhosis severity as assessed by Child Pugh, MELD
and MELD-Na scores. RI also had a prognostic value compa-
rable with MELD score. Oral midodrine was not found to
improve renal hemodynamics as assessed by RI in patients
with highest risk.
We recommend that RI should be determined initially for
every cirrhotic patient and then to be followed on routine fol-
low up visits every 6–12 months with patients with high RI fol-
lowed up at shorter interval than others. Yet, still prospective
studies over larger populations for variable long and short
term survival times, are needed for conﬁrming RI importance
in assessment of liver cirrhosis severity and prognosis.
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